ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Journal of Long-Term Effects of Medical Implants
SJR: 0.145 SNIP: 0.491 CiteScore™: 0.89

ISSN 印刷: 1050-6934
ISSN オンライン: 1940-4379

Journal of Long-Term Effects of Medical Implants

DOI: 10.1615/JLongTermEffMedImplants.2015012728
pages 225-235

Cost Effectiveness and Economic Impact of the KineSpring® Knee Implant System in the Treatment of Knee Osteoarthritis in Spain

Dan Strain
Global Research Solutions, Inc., Burlington, Ontario, Canada
Chuan Silvia Li
Global Research Solutions, Inc., Burlington, Ontario, Canada; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
Mark Phillips
Global Research Solutions, Inc., Burlington, Ontario, Canada
Olga Monteagudo Piqueras
Department of Quality Research, Murcia Health Council, Murcia, Spain
Mohit Bhandari
CLARITY Research Group, McMaster University, Department of Orthopedic Surgery Musculoskeletal Research Unit, Canada and Division of Orthopaedic Surgery and Department of Clinical Epidemiology & Biostatistics, Hamilton General Hospital, Canada

要約

We investigated the efficacy and cost effectiveness of the KineSpring System in the Spanish healthcare system, as compared to other standard treatments methods. Cost-utility ratios were calculated using derived cost data and we calculated quality-adjusted life years (QALYs) gained for each method of treatment. Cost-utility ratios were calculated assuming lifetime and 10-year durability. Assuming lifetime durability, cost-utility ratios of total knee arthroplasty (TKA), unicompartmental knee arthroplasty (UKA), high tibial osteotomy (HTO), KineSpring System, and conservative treatments, compared to no treatment, are €2348 ± 70/QALYs, €2040 ± 61/QALYs, €2281 ± 68/ QALY, €1669 ± 268/QALYs, and €11,688 ± 2185/QALYs, respectively. Assuming a treatment durability of 10 years, the cost-utility ratio of TKA, UKA, HTO, KineSpring System, and conservative treatments, compared to no treatment, are €4884 ± 323/QALYs, €4243 ± 280/QALYs, €4744 ± 313/QALYs, €3757 ± 1353/QALYs, and €10,575 ± 4414/QALYs, respectively. In comparison to current standard-of-care treatments, the KineSpring System has a favorable cost-utility ratio, making it an effective treatment option and a suitable cost-saving alternative. The KineSpring System is associated with lower cost and increased QALYs.


Articles with similar content:

Cost-Effectiveness and Economic Impact of the KineSpring® Knee Implant System in the Treatment of Knee Osteoarthritis in Italy
Journal of Long-Term Effects of Medical Implants, Vol.23, 2013, issue 2-03
Mohit Bhandari, Maurilio Marcacci, Stefano Zaffagnini, Chuan Silvia Li
Cost-Effectiveness and Economic Impact of the KineSpring® Knee Implant System in the Treatment of Knee Osteoarthritis in the United Kingdom
Journal of Long-Term Effects of Medical Implants, Vol.23, 2013, issue 2-03
Alisha Hak, Mohit Bhandari, Chuan Silvia Li
Cost-Effectiveness of Unicompartmental Knee Arthroplasty, High Tibial Osteotomy, and KineSpring® Knee Implant System for Unicompartmental Osteoarthritis of the Knee
Journal of Long-Term Effects of Medical Implants, Vol.23, 2013, issue 2-03
Mohit Bhandari, Chuan Silvia Li
Risk Factors Associated with Adjacent and Remote- Level Pathologic Vertebral Compression Fracture Following Balloon Kyphoplasty: 2-Year Follow-Up Comparison Versus Conservative Treatment
Journal of Long-Term Effects of Medical Implants, Vol.25, 2015, issue 4
Donald Hohman, Chetan Deshpande, Michael J. Faloon, Conor Dunn, Nicholas Beckloff, Mark Ruoff, Dipak V. Patel
Treatment Preferences of Patients with Early Knee Osteoarthritis: A Decision Board Analysis Assessing High Tibial Osteotomy versus the KineSpring® Knee Implant System
Journal of Long-Term Effects of Medical Implants, Vol.23, 2013, issue 2-03
Mohit Bhandari, Rudolf W. Poolman, Chuan Silvia Li